The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

It’s a question laid to rest years ago, as studies showed no evidence that the preservative causes any health problems.

The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

Secretary Robert F. Kennedy Jr. has opened a new chapter of federal vaccine policy that invites questions on issues long ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines.The FDA is expanding warnings on Pfizer and ...